Company press releases

Displaying 51 - 100 of 222 results
Released Company Title Industry Topic
11 Apr 2023
07:00 CEST 		BIOCARTIS Press release Biocartis Group NV: Biocartis Announces Publication of 2022 Annual Report 20101025 Health Services Corporate life
11 Apr 2023
07:00 CEST 		BIOCARTIS Persbericht Biocartis Group NV: Biocartis kondigt publicatie 2022 jaarverslag aan 20101025 Health Services Corporate life
04 Apr 2023
07:00 CEST 		BIOCARTIS Persbericht Biocartis Group NV: Biocartis en APIS Assay Technologies tekenen samenwerkingsovereenkomst voor de ontwikkeling en commercialisering van een subtyperingstest voor borstkanker op het Idylla™ platform 20101025 Health Services Commercial operations
04 Apr 2023
07:00 CEST 		BIOCARTIS Press release Biocartis Group NV: Biocartis and APIS Assay Technologies Sign Collaboration to Develop and Commercialise a Breast Cancer Subtyping Test on the Idylla™ platform 20101025 Health Services Commercial operations
31 Mar 2023
17:40 CEST 		BIOCARTIS Persbericht Biocartis Group NV: Openbaarmaking van uitstaande stemrechtverlenende effecten 20101025 Health Services Other subject
31 Mar 2023
17:40 CEST 		BIOCARTIS Press release Biocartis Group NV: Disclosure of Outstanding Voting Securities 20101025 Health Services Other subject
29 Mar 2023
07:00 CEST 		BIOCARTIS Persbericht Biocartis Group NV: Biocartis zal jaarverslag 2022 publiceren op 11 april 2023 20101025 Health Services Other subject
29 Mar 2023
07:00 CEST 		BIOCARTIS Press release Biocartis Group NV: Biocartis To Publish 2022 Annual Report on 11 April 2023 20101025 Health Services Other subject
03 Mar 2023
17:40 CET 		BIOCARTIS Press release Biocartis Group NV: Disclosure of transparency notification 20101025 Health Services Other subject
03 Mar 2023
17:40 CET 		BIOCARTIS Persbericht Biocartis Group NV: Openbaarmaking van transparantiekennisgeving 20101025 Health Services Other subject
02 Mar 2023
07:00 CET 		BIOCARTIS Press release Biocartis Group NV: Biocartis announces the US FDA 510(k) clearance for the Idylla™ MSI Test 20101025 Health Services Other subject
02 Mar 2023
07:00 CET 		BIOCARTIS Persbericht Biocartis Group NV: Biocartis maakt de goedkeuring bekend van de 510(k) door de US FDA van de Idylla™ MSI Test 20101025 Health Services Other subject
28 Feb 2023
17:55 CET 		BIOCARTIS Press release Biocartis Group NV: Disclosure of Outstanding Voting Securities 20101025 Health Services Other subject
28 Feb 2023
17:55 CET 		BIOCARTIS Persbericht Biocartis Group NV: Openbaarmaking van uitstaande stemrechtverlenende effecten 20101025 Health Services Other subject
24 Feb 2023
07:00 CET 		BIOCARTIS Press release Biocartis Group NV: Biocartis Creates New Share Option Plan and Cancels Outstanding Pool under Existing Share Option Plans 20101025 Health Services Other subject
24 Feb 2023
07:00 CET 		BIOCARTIS Persbericht Biocartis Group NV: Biocartis Creëert Nieuw Inschrijvingsrechtenplan en Vernietigt Uitstaande Pool onder Bestaande Inschrijvingsrechtenplannen 20101025 Health Services Other subject
23 Feb 2023
07:00 CET 		BIOCARTIS Persbericht Biocartis Group NV: Biocartis maakt resultaten 2022 en vooruitzichten 2023 bekend 20101025 Health Services Other subject
23 Feb 2023
07:00 CET 		BIOCARTIS Press release Biocartis Group NV: Biocartis announces 2022 results and 2023 outlook 20101025 Health Services Other subject
22 Feb 2023
07:00 CET 		BIOCARTIS Persbericht Biocartis Group NV: Biocartis kondigt wijziging in Raad van Bestuur aan 20101025 Health Services Other subject
22 Feb 2023
07:00 CET 		BIOCARTIS Press release Biocartis Group NV: Biocartis announces change in Board composition 20101025 Health Services Other subject
16 Feb 2023
07:00 CET 		BIOCARTIS Persbericht Biocartis Group NV: Biocartis kondigt 2022 jaarresultaten aan op 23 februari 2023 20101025 Health Services Other subject
16 Feb 2023
07:00 CET 		BIOCARTIS Press release Biocartis Group NV: Biocartis Announces 2022 Full Year Results on 23 February 2023 20101025 Health Services Other subject
09 Feb 2023
07:00 CET 		BIOCARTIS Persbericht Biocartis Group NV: BIOCARTIS MAAKT DE LANCERING BEKEND VAN DE EERSTE ASSAY ONTWIKKELD MET DE NIEUWE IDYLLA™ FLEX-TECHNOLOGIE 20101025 Health Services Other subject
09 Feb 2023
07:00 CET 		BIOCARTIS Press release Biocartis Group NV: Biocartis Announces the Launch of the First Assay Developed With the New Idylla™ Flex Technology 20101025 Health Services Other subject
31 Jan 2023
17:40 CET 		BIOCARTIS Press release Biocartis Group NV: Disclosure of Outstanding Voting Securities 20101025 Health Services Other subject
31 Jan 2023
17:40 CET 		BIOCARTIS Persbericht Biocartis Group NV: Openbaarmaking van uitstaande stemrechtverlenende effecten 20101025 Health Services Other subject
17 Jan 2023
17:40 CET 		BIOCARTIS Press release Biocartis Group NV: BIOCARTIS MEETS 2022 KEY OBJECTIVES 20101025 Health Services Commercial results
17 Jan 2023
17:40 CET 		BIOCARTIS Persbericht Biocartis Group NV: BIOCARTIS BEHAALT BELANGRIJKSTE 2022 DOELSTELLINGEN 20101025 Health Services Commercial results
16 Jan 2023
17:40 CET 		BIOCARTIS Press release Biocartis Group NV: Completion of Comprehensive Recapitalization Transactions 20101025 Health Services Corporate life
16 Jan 2023
17:40 CET 		BIOCARTIS Persbericht Biocartis Group NV: Voltooiing van alomvattende herkapitalisatie transacties 20101025 Health Services Corporate life
04 Jan 2023
17:40 CET 		BIOCARTIS Press release Biocartis Group NV: Disclosure of transparency notifications 20101025 Health Services Other financial transaction
04 Jan 2023
17:40 CET 		BIOCARTIS Persbericht Biocartis Group NV: Openbaarmaking van transparantiekennisgevingen 20101025 Health Services Other financial transaction
22 Dec 2022
17:45 CET 		BIOCARTIS Press release Biocartis Group NV: Disclosure of a transparency notification 20101025 Health Services Other financial transaction
22 Dec 2022
17:45 CET 		BIOCARTIS Persbericht Biocartis Group NV: Openbaarmaking van een transparantiekennisgeving 20101025 Health Services Other financial transaction
22 Dec 2022
17:40 CET 		BIOCARTIS Persbericht Biocartis Group NV: Openbaarmaking van uitstaande stemrechtverlenende effecten 20101025 Health Services Change in Capital
22 Dec 2022
17:40 CET 		BIOCARTIS Press release Biocartis Group NV: Disclosure of Outstanding Voting Securities 20101025 Health Services Change in Capital
16 Dec 2022
17:40 CET 		BIOCARTIS Persbericht Biocartis Group NV: Voltooiing van verplichte conversie 20101025 Health Services Other financial transaction
16 Dec 2022
17:40 CET 		BIOCARTIS Press release Biocartis Group NV: Completion of Mandatory Conversion 20101025 Health Services Other financial transaction
09 Dec 2022
17:40 CET 		BIOCARTIS Persbericht Biocartis Group NV: Openbaarmaking van transparantiekennisgevingen 20101025 Health Services Change in Capital
09 Dec 2022
17:40 CET 		BIOCARTIS Press release Biocartis Group NV: Disclosure of transparency notifications 20101025 Health Services Change in Capital
05 Dec 2022
17:40 CET 		BIOCARTIS Press release Biocartis Group NV: Mandatory Conversion Bondholder Notification 20101025 Health Services Other financial transaction
05 Dec 2022
17:40 CET 		BIOCARTIS Persbericht Biocartis Group NV: Kennisgeving van Verplichte Conversie aan de Obligatiehouders 20101025 Health Services Other financial transaction
02 Dec 2022
17:45 CET 		BIOCARTIS Press release Biocartis Group NV: Disclosure of a transparency notification 20101025 Health Services Other financial transaction
02 Dec 2022
17:45 CET 		BIOCARTIS Persbericht Biocartis Group NV: Openbaarmaking van een transparantiekennisgeving 20101025 Health Services Other financial transaction
02 Dec 2022
17:40 CET 		BIOCARTIS Press release Biocartis Group NV: Disclosure of Outstanding Voting Securities 20101025 Health Services Change in Capital
02 Dec 2022
17:40 CET 		BIOCARTIS Persbericht Biocartis Group NV: Openbaarmaking van uitstaande stemrechtverlenende effecten 20101025 Health Services Change in Capital
30 Nov 2022
07:00 CET 		BIOCARTIS Press release Biocartis Group NV: Disclosure of Outstanding Voting Securities 20101025 Health Services Change in Capital
30 Nov 2022
07:00 CET 		BIOCARTIS Persbericht Biocartis Group NV: Openbaarmaking van uitstaande stemrechtverlenende effecten 20101025 Health Services Change in Capital
29 Nov 2022
15:15 CET 		BIOCARTIS Press release Biocartis Group NV: Biocartis Announces Successful Rights Offering 20101025 Health Services Change in Capital
29 Nov 2022
15:15 CET 		BIOCARTIS Persbericht Biocartis Group NV: Biocartis kondigt succesvolle aandelenuitgifte met voorkeurrecht aan 20101025 Health Services Change in Capital